MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-17-0013733
Zazen Pharma Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹28.58 Cr
▲ 19% YoY
Net profit · FY 2025
₹1 Cr
Net margin 3.5%
EBITDA · FY 2025
₹2.36 Cr
EBITDA margin 8.2%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Open charges
₹49.95 Cr
Satisfied ₹3.83 Cr
Company age
29 yrs
Est. 1997
Directors on board
2
As per MCA filings
About Zazen Pharma Private Limited
Data last updated:
Zazen Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 June 1997 and has been in existence for over 29 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1997PTC108726. Its GSTIN is 27AAACZ0506B1ZW (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rupal Haresh Mehta and Mehul Haresh Mehta.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 302 Adinath Apt51 Tps Road Plot No 152 Borivli(W), Mumbai, Maharashtra, India – 400092.
As per the financials filed for FY 2025, the company reported a revenue of ₹28.58 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹1 Cr (net margin 3.5%) and EBITDA of ₹2.36 Cr (EBITDA margin 8.2%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 21% over five years.
The company is associated with 1 brand: Zazen Pharma. As per MCA filings, the company has open charges of ₹49.95 Cr and satisfied charges of ₹3.83 Cr on record. Court records list 3 cases involving the company, including 3 filed against it; 1 case is pending.
Zazen Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-17-0013733). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website zazenpharma.com.
Company details
CIN U24230MH1997PTC108726
Registration Number 108726
Incorporation Date 12 June 1997
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-17-0013733
Recognitions & Rankings of Zazen Pharma
Contact details
Zazen Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its website is zazenpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address302 Adinath Apt51 Tps Road Plot No 152 Borivli(W), Mumbai, Maharashtra, India – 400092
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Zazen Pharma Private Limited, buy the company report.
Comprehensive company report
Zazen Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Zazen Pharma operates one associated brand: Zazen Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufacturing of pharmaceutical injections and eye/ear drops in India. | zazenpharma.com |
Business activity
The main business activity of Zazen Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Zazen Pharma Private Limited, buy the company report.
Financials of Zazen Pharma Private Limited
FY 2025 filings availableZazen Pharma Private Limited reported revenue of ₹28.58 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹28.58 Cr ▲ 19%
Net profit · FY 2025
₹1 Cr margin 3.5%
EBITDA · FY 2025
₹2.36 Cr margin 8.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▼ 4%
5 years · compounded
▲ 21%
EBITDA CAGR growth
1 year
▲ 105%
3 years · compounded
▼ 3%
5 years · compounded
▲ 18%
Revenue has grown at a compounded annual rate (CAGR) of 21% over five years, including 19% growth in the latest year. EBITDA rose 105% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.36 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.2% | ||||
| Net Profit Margin | 3.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Zazen Pharma Private Limited, buy the company report.
Board of directors of Zazen Pharma Private Limited
Zazen Pharma has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupal Haresh Mehta | Director | 16 Apr 2021 | 5 Years 6 Months | Current |
| Mehul Haresh Mehta | Director | 12 Jun 1997 | 29 Years 4 Months | Current |
Peer comparison
Zazen Pharma Private Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Torino Laboratories Private Limited | ₹28.73 Cr (FY 2025) | 156.0% | Mumbai, Maharashtra, India | |||
| Goldfish Pharma Private Limited | ₹28.71 Cr (FY 2024) | -6.0% | Hyderabad, Telangana, India | |||
| Ceego Labs Private Limited | ₹28.61 Cr (FY 2025) | 5.0% | Chennai, Tamil Nadu, India | |||
| Texas Lifesciences Private Limited | ₹28.6 Cr (FY 2025) | 12.0% | Ahmedabad, Gujarat, India | |||
| Ives Drugs ( India) Pvt.Ltd. | ₹28.6 Cr (FY 2025) | -8.0% | Indore, Madhya Pradesh, India | |||
| Zazen Pharma Private Limitedthis company | ₹28.58 Cr (FY 2025) | ₹1 Cr | 3.5% | 19.0% | Mumbai, Maharashtra, India | |
| Dr. Edwin Medilabs Private Limited | ₹28.56 Cr (FY 2024) | 3.0% | Kurali, Punjab, India | |||
| Biovencer Healthcare Private Limited | ₹28.51 Cr (FY 2025) | -1.0% | Greater Noida, Uttar Pradesh, India | |||
| Alicon Pharmaceutical Private Limited | ₹28.34 Cr (FY 2024) | 28.0% | Palghar, Maharashtra, India |
To see the full peer comparison of Zazen Pharma Private Limited, buy the company report.
Auditor
Zazen Pharma Private Limited is audited by S R R & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S R R & CO | FY 2022 | 119254W |
Shareholding
The shareholding of Zazen Pharma Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Zazen Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹49.95 Cr
Satisfied charges
₹3.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Jan 2026 | 101228916 | Others | ₹50 Lakh | Open | |
| 02 Jun 2025 | 101155051 | State Bank of India | ₹36.75 Cr | Open | |
| 26 May 2025 | 101103403 | Others | ₹4 Cr | Open | |
| 21 Jan 2025 | 101044023 | Others | ₹2.23 Cr | Open | |
| 27 Nov 2024 | 101019238 | Others | ₹16.37 Lakh | Open |
To see the full charge records of Zazen Pharma Private Limited, buy the company report.
Total charge records: 26 View all charges
Legal cases
Zazen Pharma Private Limited has 3 court cases on record: 3 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed against the company
3
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
| High courts | 1 | 1 | 0 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Writ petition | Filed against the company by Merlin Pharma (P) Ltd. | Disposed |
| District court, Thane, Maharashtra | Court case (R.C.C.) | Filed against the company by an individual | Pending |
| District court, Mumbai Motor Accident Claims T, Maharashtra | Motor accident claim | Filed against the company by an individual | Disposed |
To see the full case history of Zazen Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Zazen Pharma Private Limited has 10 MSME Form 1 returns on record between 2019 and 2023, listing 797 overdue payments to 13 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 13)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| Sheth Impression LLP | |||
| Kishore Ampoules Pvt Ltd | |||
| an individual supplier |
To see the full MSME payment records of Zazen Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Zazen Pharma has 1 associated company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
1
Associated companies
GST
Zazen Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACZ0506B1ZW | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Zazen Pharma Private Limited, buy the company report.
Recent activity
Zazen Pharma Private Limited has 6 board changes on record since 1997: 2 appointments and 4 cessations. The latest: Rupal Haresh Mehta ceased to be Additional Director on 30 Nov 2021.
Charges
A charge with Others amounted to Rs. 50.00 Lakh with Charge ID 101228916 was registered on 14 Jan 2026.
Charges
A charge with State Bank Of India of Rs. 3,675.00 Lakh registered on 02 Jun 2025 with Charge ID 101155051 was modified on 22 Dec 2025.
AGM
Zazen Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 3,675.00 Lakh with Charge ID 101155051 was registered on 02 Jun 2025.
Charges
A charge with Others amounted to Rs. 400.00 Lakh with Charge ID 101103403 was registered on 26 May 2025.
Filing
Zazen Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Charges
A charge with Others of Rs. 223.00 Lakh registered on 21 Jan 2025 with Charge ID 101044023 was modified on 23 Jan 2025.
Charges
A charge with Others amounted to Rs. 223.00 Lakh with Charge ID 101044023 was registered on 21 Jan 2025.
Charges
A charge with Others amounted to Rs. 16.37 Lakh with Charge ID 101019238 was registered on 27 Nov 2024.
Charges
A charge with Others amounted to Rs. 3.46 Lakh with Charge ID 101013631 was registered on 18 Nov 2024.
Charges
A charge registered on 12 Mar 2018 via Charge ID 100168656 with Others was fully satisfied on 21 May 2024.
Charges
A charge registered on 29 Mar 2016 via Charge ID 100046399 with Others was fully satisfied on 21 May 2024.
43 earlier events are in the company report.
Frequently asked questions
Zazen Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 June 1997 (29+ years old) and is registered under CIN U24230MH1997PTC108726.
Zazen Pharma has 2 current directors:
- Rupal Haresh Mehta - Director
- Mehul Haresh Mehta - Director
The latest financial statements of Zazen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Zazen Pharma is 27AAACZ0506B1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Zazen Pharma is U24230MH1997PTC108726. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Zazen Pharma has 3 court cases on record: 3 filed against it. 1 is pending. Most are in the district courts.
Zazen Pharma was incorporated on 12 June 1997, making it 29+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Zazen Pharma by revenue are Torino Laboratories Private Limited, Goldfish Pharma Private Limited, Ceego Labs Private Limited, Texas Lifesciences Private Limited, Ives Drugs ( India) Pvt.Ltd. and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rupal Haresh Mehta ceased to be Additional Director on 30 Nov 2021. Niraj Harshad Dholakiya ceased to be Additional Director on 16 Apr 2021. Rupal Haresh Mehta was appointed as Director on 16 Apr 2021. Zazen Pharma has 6 board changes on record in total.
Yes, Zazen Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-17-0013733).
Zazen Pharma has 10 MSME Form 1 returns on record between 2019 and 2023, listing 797 overdue payments to 13 micro and small suppliers. The latest return was filed on 04 Sep 2023.
Zazen Pharma can be reached through the website zazenpharma.com. Its registered office is in Mumbai, Maharashtra, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages